HomeCompareAHFCF vs JNJ

AHFCF vs JNJ: Dividend Comparison 2026

AHFCF yields 350.88% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AHFCF wins by $4457.88M in total portfolio value
10 years
AHFCF
AHFCF
● Live price
350.88%
Share price
$0.57
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4457.90M
Annual income
$2,856,459,891.66
Full AHFCF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AHFCF vs JNJ

📍 AHFCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAHFCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AHFCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AHFCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AHFCF
Annual income on $10K today (after 15% tax)
$29,824.56/yr
After 10yr DRIP, annual income (after tax)
$2,427,990,907.91/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, AHFCF beats the other by $2,427,990,204.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AHFCF + JNJ for your $10,000?

AHFCF: 50%JNJ: 50%
100% JNJ50/50100% AHFCF
Portfolio after 10yr
$2228.96M
Annual income
$1,428,230,359.72/yr
Blended yield
64.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AHFCF
No analyst data
Altman Z
0.1
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AHFCF buys
0
JNJ buys
0
No recent congressional trades found for AHFCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAHFCFJNJ
Forward yield350.88%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4457.90M$20.0K
Annual income after 10y$2,856,459,891.66$827.78
Total dividends collected$4304.93M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AHFCF vs JNJ ($10,000, DRIP)

YearAHFCF PortfolioAHFCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$45,788$35,087.72$10,676$355.77+$35.1KAHFCF
2$199,141$150,148.28$11,407$389.39+$187.7KAHFCF
3$823,388$610,307.32$12,198$426.53+$811.2KAHFCF
4$3,239,377$2,358,351.44$13,056$467.62+$3.23MAHFCF
5$12,137,380$8,671,246.26$13,987$513.12+$12.12MAHFCF
6$43,351,150$30,364,154.13$14,998$563.56+$43.34MAHFCF
7$147,742,580$101,356,848.81$16,098$619.52+$147.73MAHFCF
8$480,914,923$322,830,362.62$17,295$681.69+$480.90MAHFCF
9$1,496,673,226$982,094,258.32$18,599$750.82+$1496.65MAHFCF
10$4,457,900,243$2,856,459,891.66$20,022$827.78+$4457.88MAHFCF

AHFCF vs JNJ: Complete Analysis 2026

AHFCFStock

Flow Capital Corp. operates as an alternative asset investor and advisor in Canada, the United States, and the United Kingdom. It engages in the cashflow-oriented investments using venture debt and revenue-linked royalty financing structures in businesses; and various advisory services. Flow Capital Corp. is based in Vancouver, Canada.

Full AHFCF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AHFCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AHFCF vs SCHDAHFCF vs JEPIAHFCF vs OAHFCF vs KOAHFCF vs MAINAHFCF vs ABBVAHFCF vs MRKAHFCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.